Results 181 to 190 of about 47,865 (277)
Pathogen‐reduced plasma, cryoprecipitate reduced for therapeutic plasma exchange
Abstract Background Therapeutic plasma exchange (TPE) for thrombotic thrombocytopenic purpura (TTP) and auto‐immune disorders involves repeated patient exposure to allogenic plasma with the risk of transfusion‐transmitted infection (TTI).
Florian Tupin +6 more
wiley +1 more source
von Willebrand Factor Deficiency Inhibits Endothelial-to-Mesenchymal Transition to Attenuate Pulmonary Fibrosis. [PDF]
Wang W +8 more
europepmc +1 more source
Immunopurification of Human Factor VIII/vWF Complex from Plasma [PDF]
Odile Méjan +5 more
openalex +1 more source
ABSTRACT Background In humans, deficiency of a disintegrin‐like and metalloprotease with thrombospondin type 1 motifs, number 13 (ADAMTS13), a von Willebrand factor (vWF) cleaving protease, is an underlying mechanism for thrombosis. The role of ADAMTS13 in canine thromboembolic disease is largely unknown.
Ashley R. Wilkinson +2 more
wiley +1 more source
Reversible formation of von-Willebrand-factor-platelet aggregates in microvascular blood flow. [PDF]
Topuz A, Hoore M, Gompper G, Fedosov DA.
europepmc +1 more source
Re-establishment of VWF-dependent Weibel-Palade bodies in VWD endothelial cells
Sandra L. Haberichter +5 more
openalex +1 more source
Abstract Endothelial dysfunction drives obesity‐related complications. Doppler ultrasound measurement of blood flow during 1‐min passive leg movements (PLM) is a valuable non‐invasive tool for assessing endothelial function and nitric oxide (NO)‐mediated vasodilation.
Lucrezia Zuccarelli +13 more
wiley +1 more source
Von Willebrand disease: classification and epidemiology. [PDF]
Castaman G, Bramante Federici A.
europepmc +1 more source

